Vancouver Coastal Health Research Institute (VCHRI) is proud to recognize the outstanding contributions of long-term research staff with the 2024 Research Excellence Staff Award (RESA). This competition acknowledges staff members with 10 or more years of service who have demonstrated research excellence through mentorship, building a culture of research and upholding the VCHRI values of integrity, accountability, collaboration, equity and community- and patient-focus. This year’s recipient will receive $15,000 in lab funding, as well as a personal honorarium for their dedicated work.
A Single Arm, Open Label, Multicenter Clinical Investigation to Evaluate the Clinical Safety and Performance of the CorNeat Keratoprosthesis, for Treatment of Corneal Blindness
The sudden onset and severity of de novo metastatic prostate cancer makes it one of the deadliest cancers affecting men. Characterised by additional aggressive cancer lesions in other parts of the body, the condition is found in around five to 10 per cent of prostate cancer patients at the time they are first diagnosed.
A Phase IB, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Selnoflast in Participants with Moderate to Severe Asthma
Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
In a recent announcement, Research Infosource Inc., a leading Canadian research, consulting and publishing firm, has revealed its annual ranking of Canada’s top 40 research hospitals. Vancouver Coastal Health Authority (Vancouver Coastal Health Research Institute (VCHRI) and Providence Health Care Research Institute), proudly occupies the fourth position, with $168.8 million in research funding for the year 2022.
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
For Nate*, the many gambling facilities near his home in Japan were an easy source of entertainment. So much so that he dreamed of one day travelling to Las Vegas, Nevada, to visit the seemingly endless stretch of casinos throughout the city and play on their rows of glimmering, melodious slot machines. Then, in 2022, that dream became a reality.
